News Archive

May 12, 2020

Kaléo Announces ALLERJECT® (epinephrine injection, USP) Auto-Injector Will Be Available for Canadians at Risk for Anaphylaxis Starting May 19, 2020

May 12, 2020

Kaléo annonce qu’à partir du 19 mai 2020 l’auto-injecteur ALLERJECT® (épinéphrine injectable, USP) sera à la disposition des Canadiens à risque d’anaphylaxie.

July 11, 2019

Walgreens and Kaléo Expand Retail Pharmacy Collaboration to Include AUVI-q® (epinephrine injection, USP) 0.1 mg, the Only FDA-Approved Epinephrine Auto-Injector for Infants and Toddlers, 16.5 – 33 lbs

December 12, 2018

Authorized Generic for EVZIO® (naloxone HCl injection) to be Available at a Reduced List Price of $178

September 6, 2018

Walgreens and Kaléo Partner to Address Epinephrine Auto-Injector Supply Issues, Providing Patients Access to AUVI-Q® (epinephrine injection, USP) Through Walgreens Locations Nationwide

August 29, 2018

AUVI-Q® (epinephrine injection, USP) Available in Canada Starting September 7

August 14, 2018

Kaléo Confirms U.S. Availability of AUVI-Q® (epinephrine injection, USP) Auto-injector for Back-to-School Season

April 26, 2018

With Life-Threatening Allergies Diagnosed in Infancy, Kaléo Announces Availability of First and Only FDA-Approved Epinephrine Auto-Injector (EAI) for Infants and Toddlers Weighing 16.5 to 33 Pounds (7.5 to 15 kilograms)

April 18, 2018

NASCAR Driver Elliott Sadler Teams Up with Kaléo about AUVI-Q® (Epinephrine Injection, USP) to Raise Awareness of Life-Threatening Allergies

April 5, 2018

EVZIO® (naloxone HCl injection, USP) Auto-Injector Now Available to Patients in Select States Without a Prescription Through Kaléo’s New Virtual Standing Order Pilot Program and to Government Agencies at a Direct Purchase Price

February 21, 2018

Cabell-Huntington Health Department and the City of Huntington Fire Department Officials Named Co-Recipients of the 2017 Kaléo Cares Award

January 11, 2018

More than 5000 Lives Reported Saved with Help of EVZIO® (naloxone HCl injection) Auto-injectors

November 20, 2017

U.S. FDA Approves Kaléo’s AUVI-Q® (Epinephrine Injection, USP) 0.1 mg Auto-Injector for Life-Threatening Allergic Reactions in Infants and Small Children

October 24, 2017

Kaléo Along with National Advocacy Organizations Launch the “No Appetite for Bullying” Initiative

September 1, 2017

Kaléo Donates Thousands of AUVI-Q® (epinephrine injection, USP) and EVZIO® (naloxone HCl injection) Auto-injectors to Hurricane Harvey Relief Efforts

August 7, 2017

Kaléo Announces AUVI-Q® (epinephrine injection, USP) Charitable Donation Program for All Public Elementary Schools in the United States

July 27, 2017

U.S. FDA Grants Priority Review for an Epinephrine Auto-Injector in Development by Kaléo Specifically for Infants and Small Children

June 22, 2017

News